日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Allosteric inhibitors targeting the calmodulin-PIP2 interface of SK4 K+ channels for atrial fibrillation treatment

针对 SK4 K+ 通道钙调蛋白-PIP2 界面的变构抑制剂用于房颤治疗

Shira Burg, Shir Shapiro, Asher Peretz, Elvira Haimov, Boris Redko, Adva Yeheskel, Luba Simhaev, Hamutal Engel, Avi Raveh, Ariel Ben-Bassat, Michael Murninkas, Rotem Polak, Yoni Haitin, Yoram Etzion, Bernard Attali

Anti-Cancer Effects of Cyclic Peptide ALOS4 in a Human Melanoma Mouse Model

环肽 ALOS4 在人类黑色素瘤小鼠模型中的抗癌作用

Bar Levi, Shiri Yacobovich, Michael Kirby, Maria Becker, Oryan Agranyoni, Boris Redko, Gary Gellerman, Albert Pinhasov, Igor Koman, Elimelech Nesher

Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma

开发用于治疗人类转移性黑色素瘤的新型非 RGD 环肽药物偶联物

Boris Redko, Helena Tuchinsky, Tamar Segal, Dror Tobi, Galia Luboshits, Osnat Ashur-Fabian, Albert Pinhasov, Gabi Gerlitz, Gary Gellerman

Novel synthetic cyclic integrin αvβ3 binding peptide ALOS4: Antitumor activity in mouse melanoma models

新型合成环状整合素 αvβ3 结合肽 ALOS4:小鼠黑色素瘤模型中的抗肿瘤活性

Shiri Yacobovich, Lena Tuchinsky, Michael Kirby, Tetiana Kardash, Oryan Agranyoni, Elimelech Nesher, Boris Redko, Gary Gellerman, Dror Tobi, Katerina Gurova, Igor Koman, Osnat Ashur Fabian, Albert Pinhasov